Related Experiment Video
Updated: Oct 2, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Factors Predicting Short Term Outcome in Children With Idiopathic Nephrotic Syndrome: A Prospective Cohort Study
Irshad Bajeer1, Sabeeta Khatri1, Seema Hashmi1
1Pediatric Nephrology, Sindh Institute of Urology and Transplantation, Karachi, PAK.
Insights
Delayed steroid response and younger age are key predictors for relapses in children with idiopathic nephrotic syndrome (INS). Early responders experienced longer remission periods, suggesting treatment timing influences relapse patterns.
Area of Science:
- Pediatric Nephrology
- Internal Medicine
- Clinical Research
Background:
- Idiopathic nephrotic syndrome (INS) is a common kidney disorder in children.
- Relapses are a significant concern, impacting long-term outcomes.
- Identifying predictors of relapse is crucial for effective management.
Purpose of the Study:
- To determine risk factors associated with relapses in children diagnosed with INS.
- To investigate the relationship between steroid response time and relapse patterns.
Main Methods:
- Prospective follow-up of 57 children with their first INS episode for at least one year.
- Categorization into early (<8 days) and late (≥8 days) steroid responders.
- Comparison of remission times, time to first relapse, and relapse patterns.
Main Results:
- Younger age (1-4 years) showed a trend towards higher relapse propensity (p=0.11).
- Delayed steroid response correlated with a longer time to first relapse (3.1 ± 5.2 days vs. 1.6 ± 3.8 days).
- 51% of children achieved complete remission at the last follow-up.
Conclusions:
- Delayed steroid response in children with INS may predict a longer time to the first relapse.
- Younger age at presentation appears to be associated with the number of relapses.
- These factors can aid in predicting and managing INS relapses.
Abstract:
Objective The objective of the article is to determine the risk factors associated with relapses in children with idiopathic nephrotic syndrome (INS). Material and methods Fifty-seven children with the first episode of INS were included and followed up prospectively for a minimum period of one year to identify the risk factors related to relapses. The study subjects were divided into early (less than eight days) and late (equal to or more than eight days) responder groups and were compared in terms of the number of days to achieve complete remission, time to first relapse, and the pattern of relapse at the last follow-up. Results Of the 57 children, 32 (56%) were male and 25 (44%) female. The mean age of the study cohort was 5.3 ± 3 years. Sixteen (55%) children with ages ranging from one to four years had a higher propensity to develop relapse, although the p-value (p=0.11) was not significant. Gender analysis did not reveal any significant correlation (p=0.32); however, a higher proportion of males (n=17; 63%) responded within eight days of starting steroids than female counterparts (n=10; 37%). Microscopic hematuria at the disease onset was seen in 12 (21%) children, and out of them, five (41.6%) remained in complete remission. The mean time to achieve complete remission was 8.1 ± 3.5 days, while the early responder group had delayed time to first relapse as compared to the late responders (3.1 ± 5.2 vs. 1.6± 3.8; p=0.21). Among all the study participants, a significant number of children (n=20; 51%) were in complete remission at their last follow-up visit. Baseline serum albumin, cholesterol, body mass index (BMI), and serum creatinine had no significant difference. Conclusion The delayed response to steroids and younger age at presentation can predict the time to first relapse and number of relapses in children with INS, respectively.
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome I : Introduction
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction